Hepion Pharmaceuticals, Inc.
看多
已更新

Extremely undervalued

Overreaction to their public offering. Their cash balance would already be higher than their market cap once the offering is closed.
註釋
Have closed the position for other trades

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。